Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Vanda Pharmaceuticals Inc. (VNDA) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$56.26M |
|
$-22.59M |
|
$2.95M |
|
$53.30M |
|
$87.54M |
|
$-31.28M |
|
$2.89M |
|
$-28.39M |
|
$-28.39M |
|
$-22.59M |
|
$-22.59M |
|
$-22.59M |
|
$-22.59M |
|
$-31.28M |
|
$-29.73M |
|
59.09M |
|
59.09M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$367.50M |
|
$2.46M |
|
$233.64M |
|
$601.14M |
|
$117.87M |
|
$2.81M |
|
$17.27M |
|
$135.14M |
|
$466.00M |
|
$357.16M |
|
$466.00M |
|
59.10M |
|
| Cash Flow Statement Financials | |
$-80.03M |
|
$49.99M |
|
$-2.27M |
|
$102.78M |
|
$70.49M |
|
$-32.29M |
|
$7.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.12 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.01 |
94.75% |
|
-55.61% |
|
-55.61% |
|
-- |
|
-50.46% |
|
-40.15% |
|
$-80.92M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
1.45 |
|
1.11 |
|
80.85 |
|
-4.85% |
|
-6.32% |
|
-3.76% |
|
-4.82% |
|
$7.89 |
|
$-1.37 |
|
$-1.35 |
|